Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery

Keyphrases

• Clinical Outcomes 100%
• Cardiac Surgery 100%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 100%
• Coronary Artery Bypass Grafting 60%
• Inhibitor Therapy 40%
• Odds Ratio 30%
• Long-term Survival 20%
• Renal Failure 20%
• Hazard Ratio 10%
• Diabetes 10%
• Hypertension 10%
• Intensive Care Unit 10%
• Ejection Fraction 10%
• Consecutive Patients 10%
• Adverse Outcomes 10%
• Acute Coronary Syndrome 10%
• In-hospital Mortality 10%
• Single Institution 10%
• Inotropes 10%
• Heart Failure 10%
• New Onset 10%
• Multivariable Model 10%
• In-hospital Outcomes 10%
• Recent Myocardial Infarction 10%
• Intra-aortic Balloon Pump 10%
• Readmission Risk 10%
• Prolonged Length of Stay 10%

Medicine and Dentistry

• Heart Surgery 100%
• ACE Inhibitor 100%
• Coronary Artery Bypass Graft 60%
• Odds Ratio 30%
• Long Term Survival 20%
• Renal Failure 20%
• Diabetes 10%
• Hazard Ratio 10%
• Myocardial Infarction 10%
• Ejection Fraction 10%
• Intensive Care Unit 10%
• Adverse Outcome 10%
• Heart Failure 10%
• Acute Coronary Syndrome 10%
• Hospital Mortality 10%
• Intra-Aortic Balloon Pump 10%

Nursing and Health Professions

• Intraaortic Balloon Pump 10%